Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection
- PMID: 7508488
- DOI: 10.1002/jmv.1890420119
Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection
Abstract
Hepatitis C virus (HCV) infection is characterized by persistence of liver inflammation that often leads to end-stage liver disease, although the mechanisms are not fully understood. A hypervariable region (HVR) has been reported in the E2/NS1 region of the HCV genome, in which striking diversity is found among different HCV isolates. To investigate the association of the HVR alterations with the clinical courses of HCV infection, a longitudinal analysis of the HVR in patients with acute HCV infection was carried out. Plasma samples were obtained at several times in three patients with acute hepatitis C. Plasma RNA was extracted and reverse transcribed, and DNA fragments that included the HVR were amplified by PCR. The sequences of the HVR were directly determined from the PCR products by the dideoxy chain termination method, from which amino acid sequences were deduced. In all cases, plasma HCV-RNA disappeared with the improvement of the initial alanine aminotransferase (ALT) elevation, but HCV-RNA reappeared about 1 year later with or without deterioration of the hepatitis. In a case of sporadic acute hepatitis, the HCV in the recurrent phase had seven amino acid substitutions in the HVR compared with that in the acute phase, although no amino acid changes were noted during the initial acute phase. In a case of posttransfusion hepatitis, a marked difference was observed between the acute and the recurrent phases, with an amino acid homology of 30% (8/27). The mutation rate of the HVR had a tendency to accelerate as the HCV infection progressed to the chronic stage.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Sequence variation of the hypervariable region in HCV carriers with normal ALT levels: a comparison with symptomatic carriers.Microbiol Immunol. 1996;40(12):941-7. doi: 10.1111/j.1348-0421.1996.tb01163.x. Microbiol Immunol. 1996. PMID: 9013492
-
Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.Hepatology. 1996 Dec;24(6):1346-50. doi: 10.1002/hep.510240605. Hepatology. 1996. PMID: 8938159
-
Genomic typing of hepatitis C viruses from Korean patients: implications of genome variation in the E2/NS1 region.Biochem Biophys Res Commun. 1993 Oct 29;196(2):780-8. doi: 10.1006/bbrc.1993.2317. Biochem Biophys Res Commun. 1993. PMID: 8240354
-
[Evolution of hepatitis C virus (HCV) viremia and adaptation of HCV in persistent infection in patients with acute hepatitis].Nihon Rinsho. 1994 Jul;52(7):1852-6. Nihon Rinsho. 1994. PMID: 7521430 Review. Japanese.
-
Biomarkers in Detection of Hepatitis C Virus Infection.Pathogens. 2024 Apr 17;13(4):331. doi: 10.3390/pathogens13040331. Pathogens. 2024. PMID: 38668286 Free PMC article. Review.
Cited by
-
Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort.J Virol. 1998 Jun;72(6):4893-905. doi: 10.1128/JVI.72.6.4893-4905.1998. J Virol. 1998. PMID: 9573256 Free PMC article.
-
Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: studies of infected donor-recipient clusters.J Virol. 2000 Mar;74(6):2541-9. doi: 10.1128/jvi.74.6.2541-2549.2000. J Virol. 2000. PMID: 10684268 Free PMC article.
-
Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity.Am J Pathol. 1997 Mar;150(3):963-70. Am J Pathol. 1997. PMID: 9060834 Free PMC article.
-
Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients.J Virol. 1995 Jul;69(7):4407-12. doi: 10.1128/JVI.69.7.4407-4412.1995. J Virol. 1995. PMID: 7539508 Free PMC article.
-
HCV Glycoprotein Structure and Implications for B-Cell Vaccine Development.Int J Mol Sci. 2020 Sep 16;21(18):6781. doi: 10.3390/ijms21186781. Int J Mol Sci. 2020. PMID: 32947858 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical